• 1
    Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994: 266 (5182): 6671.
  • 2
    Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995: 378 (6559): 789792.
  • 3
    Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005: 23 (8): 16561663.
  • 4
    Pal T, Vadaparampil ST. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting. Cancer Control 2012: 19 (4): 255266.
  • 5
    Genetic/Familial High-risk Assessment: Breast and Ovarian. In: NCCN Practice Guidelies. V.3.2011 ed. Fort Washington, PA: National Comprehensive Cancer Network, 2012.
  • 6
    Riley BD, Culver JO, Skrzynia C et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2012: 21 (2): 151161.
  • 7
    Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010: 28 (5): 893901.
  • 8
    Stuckey A, Dizon D, Scalia Wilbur J et al. Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers. Gynecol Obstet Invest 2010: 69 (4): 270273.
  • 9
    Dhar SU, Cooper HP, Wang T et al. Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat 2011: 129 (1): 221227.
  • 10
    Keating NL, Stoeckert KA, Regan MM, Di Gianni L, Garber JE. Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol 2008: 26 (35): 57895796.
  • 11
    Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 2011: 61: 327359.
  • 12
    Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 2005: 42 (10): 749755.
  • 13
    Brierley KL, Blouch E, Cogswell W et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J 2012: 18 (4): 303309.